Preliminary 1Q26 Results: Sales +9.1%, Operating Profit +489.3% YoY
-
1Q26 sales KRW 66,127 million - up 9.1% YoY, down 7.1% QoQ
-
Operating profit KRW 713 million - up 489.3% YoY, up 38.2% QoQ
-
Net loss KRW 530 million - improved YoY (23.7% decrease in loss), worsened QoQ (22.4% increase in loss)
-
Preliminary figures, unaudited; subject to change upon final review
KOSPI Filing Information
-
Filing: Preliminary Operating Results (Fair Disclosure)
-
Company: Kyongbo Pharmaceutical (214390)
-
Submission: Kyongbo Pharmaceutical Co., Ltd.
-
Receipt: 04-29-2026
-
Under KRX KOSPI Market Division